nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—migraine—Prednisone—psoriasis	0.288	0.508	CpDpCtD
Cyclobenzaprine—osteoarthritis—Prednisone—psoriasis	0.278	0.492	CpDpCtD
Cyclobenzaprine—CYP1A2—Clobetasol propionate—psoriasis	0.0691	0.225	CbGbCtD
Cyclobenzaprine—CYP1A2—Methoxsalen—psoriasis	0.0363	0.118	CbGbCtD
Cyclobenzaprine—CYP2D6—Hydroxyurea—psoriasis	0.0327	0.106	CbGbCtD
Cyclobenzaprine—CYP3A4—Calcitriol—psoriasis	0.0244	0.0796	CbGbCtD
Cyclobenzaprine—CYP2D6—Cholecalciferol—psoriasis	0.0198	0.0645	CbGbCtD
Cyclobenzaprine—CYP3A4—Methoxsalen—psoriasis	0.019	0.0619	CbGbCtD
Cyclobenzaprine—CYP2D6—Cyclosporine—psoriasis	0.013	0.0424	CbGbCtD
Cyclobenzaprine—CYP3A4—Cholecalciferol—psoriasis	0.0126	0.041	CbGbCtD
Cyclobenzaprine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0109	0.0355	CbGbCtD
Cyclobenzaprine—CYP3A4—Triamcinolone—psoriasis	0.0109	0.0355	CbGbCtD
Cyclobenzaprine—CYP3A4—Betamethasone—psoriasis	0.00937	0.0305	CbGbCtD
Cyclobenzaprine—CYP3A4—Prednisolone—psoriasis	0.00924	0.0301	CbGbCtD
Cyclobenzaprine—CYP3A4—Hydrocortisone—psoriasis	0.00876	0.0285	CbGbCtD
Cyclobenzaprine—CYP3A4—Prednisone—psoriasis	0.00873	0.0284	CbGbCtD
Cyclobenzaprine—CYP2D6—Dexamethasone—psoriasis	0.00857	0.0279	CbGbCtD
Cyclobenzaprine—CYP3A4—Cyclosporine—psoriasis	0.00827	0.0269	CbGbCtD
Cyclobenzaprine—CYP3A4—Dexamethasone—psoriasis	0.00545	0.0177	CbGbCtD
Cyclobenzaprine—Decreased appetite—Mycophenolate mofetil—psoriasis	8.73e-05	0.000688	CcSEcCtD
Cyclobenzaprine—Anorexia—Hydrocortisone—psoriasis	8.72e-05	0.000687	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Mycophenolic acid—psoriasis	8.71e-05	0.000686	CcSEcCtD
Cyclobenzaprine—Stomatitis—Methotrexate—psoriasis	8.7e-05	0.000685	CcSEcCtD
Cyclobenzaprine—Malaise—Dexamethasone—psoriasis	8.64e-05	0.000681	CcSEcCtD
Cyclobenzaprine—Malaise—Betamethasone—psoriasis	8.64e-05	0.000681	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Triamcinolone—psoriasis	8.62e-05	0.000679	CcSEcCtD
Cyclobenzaprine—Oedema—Triamcinolone—psoriasis	8.62e-05	0.000679	CcSEcCtD
Cyclobenzaprine—Vertigo—Betamethasone—psoriasis	8.61e-05	0.000678	CcSEcCtD
Cyclobenzaprine—Vertigo—Dexamethasone—psoriasis	8.61e-05	0.000678	CcSEcCtD
Cyclobenzaprine—Syncope—Betamethasone—psoriasis	8.59e-05	0.000677	CcSEcCtD
Cyclobenzaprine—Syncope—Dexamethasone—psoriasis	8.59e-05	0.000677	CcSEcCtD
Cyclobenzaprine—Constipation—Mycophenolate mofetil—psoriasis	8.59e-05	0.000677	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Prednisone—psoriasis	8.56e-05	0.000675	CcSEcCtD
Cyclobenzaprine—Sweating—Methotrexate—psoriasis	8.55e-05	0.000674	CcSEcCtD
Cyclobenzaprine—Hypotension—Hydrocortisone—psoriasis	8.55e-05	0.000674	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Cyclosporine—psoriasis	8.49e-05	0.000669	CcSEcCtD
Cyclobenzaprine—Shock—Triamcinolone—psoriasis	8.48e-05	0.000668	CcSEcCtD
Cyclobenzaprine—Insomnia—Prednisolone—psoriasis	8.47e-05	0.000668	CcSEcCtD
Cyclobenzaprine—Alopecia—Prednisone—psoriasis	8.47e-05	0.000667	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Cyclosporine—psoriasis	8.42e-05	0.000663	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Dexamethasone—psoriasis	8.42e-05	0.000663	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Betamethasone—psoriasis	8.42e-05	0.000663	CcSEcCtD
Cyclobenzaprine—Dizziness—Mycophenolic acid—psoriasis	8.42e-05	0.000663	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Prednisolone—psoriasis	8.41e-05	0.000663	CcSEcCtD
Cyclobenzaprine—Tachycardia—Triamcinolone—psoriasis	8.41e-05	0.000663	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	8.34e-05	0.000657	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Triamcinolone—psoriasis	8.33e-05	0.000656	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Methotrexate—psoriasis	8.33e-05	0.000656	CcSEcCtD
Cyclobenzaprine—Convulsion—Betamethasone—psoriasis	8.3e-05	0.000654	CcSEcCtD
Cyclobenzaprine—Convulsion—Dexamethasone—psoriasis	8.3e-05	0.000654	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Mycophenolate mofetil—psoriasis	8.28e-05	0.000652	CcSEcCtD
Cyclobenzaprine—Insomnia—Hydrocortisone—psoriasis	8.28e-05	0.000652	CcSEcCtD
Cyclobenzaprine—Hypertension—Dexamethasone—psoriasis	8.27e-05	0.000652	CcSEcCtD
Cyclobenzaprine—Hypertension—Betamethasone—psoriasis	8.27e-05	0.000652	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Hydrocortisone—psoriasis	8.22e-05	0.000647	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	8.21e-05	0.000647	CcSEcCtD
Cyclobenzaprine—Urticaria—Cyclosporine—psoriasis	8.18e-05	0.000645	CcSEcCtD
Cyclobenzaprine—Myalgia—Betamethasone—psoriasis	8.16e-05	0.000643	CcSEcCtD
Cyclobenzaprine—Myalgia—Dexamethasone—psoriasis	8.16e-05	0.000643	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Cyclosporine—psoriasis	8.14e-05	0.000641	CcSEcCtD
Cyclobenzaprine—Anxiety—Dexamethasone—psoriasis	8.13e-05	0.00064	CcSEcCtD
Cyclobenzaprine—Anxiety—Betamethasone—psoriasis	8.13e-05	0.00064	CcSEcCtD
Cyclobenzaprine—Vomiting—Mycophenolic acid—psoriasis	8.09e-05	0.000638	CcSEcCtD
Cyclobenzaprine—Discomfort—Betamethasone—psoriasis	8.06e-05	0.000635	CcSEcCtD
Cyclobenzaprine—Discomfort—Dexamethasone—psoriasis	8.06e-05	0.000635	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Hydrocortisone—psoriasis	8.06e-05	0.000635	CcSEcCtD
Cyclobenzaprine—Rash—Mycophenolic acid—psoriasis	8.03e-05	0.000632	CcSEcCtD
Cyclobenzaprine—Dermatitis—Mycophenolic acid—psoriasis	8.02e-05	0.000632	CcSEcCtD
Cyclobenzaprine—Hepatitis—Methotrexate—psoriasis	8.01e-05	0.000631	CcSEcCtD
Cyclobenzaprine—Urticaria—Mycophenolate mofetil—psoriasis	7.98e-05	0.000629	CcSEcCtD
Cyclobenzaprine—Headache—Mycophenolic acid—psoriasis	7.97e-05	0.000628	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Hydrocortisone—psoriasis	7.95e-05	0.000627	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Methotrexate—psoriasis	7.95e-05	0.000626	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Mycophenolate mofetil—psoriasis	7.94e-05	0.000626	CcSEcCtD
Cyclobenzaprine—Fatigue—Hydrocortisone—psoriasis	7.89e-05	0.000622	CcSEcCtD
Cyclobenzaprine—Vision blurred—Prednisone—psoriasis	7.86e-05	0.00062	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Triamcinolone—psoriasis	7.85e-05	0.000619	CcSEcCtD
Cyclobenzaprine—Oedema—Betamethasone—psoriasis	7.82e-05	0.000616	CcSEcCtD
Cyclobenzaprine—Oedema—Dexamethasone—psoriasis	7.82e-05	0.000616	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Betamethasone—psoriasis	7.82e-05	0.000616	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Dexamethasone—psoriasis	7.82e-05	0.000616	CcSEcCtD
Cyclobenzaprine—Insomnia—Triamcinolone—psoriasis	7.79e-05	0.000614	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Prednisone—psoriasis	7.74e-05	0.00061	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Triamcinolone—psoriasis	7.74e-05	0.00061	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Prednisolone—psoriasis	7.72e-05	0.000608	CcSEcCtD
Cyclobenzaprine—Shock—Dexamethasone—psoriasis	7.69e-05	0.000606	CcSEcCtD
Cyclobenzaprine—Shock—Betamethasone—psoriasis	7.69e-05	0.000606	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Triamcinolone—psoriasis	7.68e-05	0.000605	CcSEcCtD
Cyclobenzaprine—Agitation—Prednisone—psoriasis	7.67e-05	0.000604	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Betamethasone—psoriasis	7.66e-05	0.000603	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Dexamethasone—psoriasis	7.66e-05	0.000603	CcSEcCtD
Cyclobenzaprine—Tachycardia—Betamethasone—psoriasis	7.63e-05	0.000601	CcSEcCtD
Cyclobenzaprine—Tachycardia—Dexamethasone—psoriasis	7.63e-05	0.000601	CcSEcCtD
Cyclobenzaprine—Angioedema—Prednisone—psoriasis	7.62e-05	0.000601	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Cyclosporine—psoriasis	7.59e-05	0.000598	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Triamcinolone—psoriasis	7.58e-05	0.000598	CcSEcCtD
Cyclobenzaprine—Nausea—Mycophenolic acid—psoriasis	7.56e-05	0.000596	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Betamethasone—psoriasis	7.56e-05	0.000596	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Dexamethasone—psoriasis	7.56e-05	0.000596	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Hydrocortisone—psoriasis	7.54e-05	0.000594	CcSEcCtD
Cyclobenzaprine—Malaise—Prednisone—psoriasis	7.52e-05	0.000593	CcSEcCtD
Cyclobenzaprine—Vertigo—Prednisone—psoriasis	7.5e-05	0.000591	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Hydrocortisone—psoriasis	7.48e-05	0.00059	CcSEcCtD
Cyclobenzaprine—Syncope—Prednisone—psoriasis	7.48e-05	0.00059	CcSEcCtD
Cyclobenzaprine—Tinnitus—Methotrexate—psoriasis	7.47e-05	0.000588	CcSEcCtD
Cyclobenzaprine—Anorexia—Betamethasone—psoriasis	7.45e-05	0.000587	CcSEcCtD
Cyclobenzaprine—Anorexia—Dexamethasone—psoriasis	7.45e-05	0.000587	CcSEcCtD
Cyclobenzaprine—Urticaria—Prednisolone—psoriasis	7.44e-05	0.000587	CcSEcCtD
Cyclobenzaprine—Fatigue—Triamcinolone—psoriasis	7.43e-05	0.000585	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.4e-05	0.000583	CcSEcCtD
Cyclobenzaprine—Asthenia—Cyclosporine—psoriasis	7.39e-05	0.000582	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Prednisone—psoriasis	7.33e-05	0.000578	CcSEcCtD
Cyclobenzaprine—Hypotension—Dexamethasone—psoriasis	7.31e-05	0.000576	CcSEcCtD
Cyclobenzaprine—Hypotension—Betamethasone—psoriasis	7.31e-05	0.000576	CcSEcCtD
Cyclobenzaprine—Pruritus—Cyclosporine—psoriasis	7.29e-05	0.000574	CcSEcCtD
Cyclobenzaprine—Urticaria—Hydrocortisone—psoriasis	7.27e-05	0.000573	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Hydrocortisone—psoriasis	7.23e-05	0.00057	CcSEcCtD
Cyclobenzaprine—Convulsion—Prednisone—psoriasis	7.23e-05	0.00057	CcSEcCtD
Cyclobenzaprine—Asthenia—Mycophenolate mofetil—psoriasis	7.21e-05	0.000568	CcSEcCtD
Cyclobenzaprine—Hypertension—Prednisone—psoriasis	7.2e-05	0.000568	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Dexamethasone—psoriasis	7.12e-05	0.000561	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Betamethasone—psoriasis	7.12e-05	0.000561	CcSEcCtD
Cyclobenzaprine—Pruritus—Mycophenolate mofetil—psoriasis	7.11e-05	0.00056	CcSEcCtD
Cyclobenzaprine—Myalgia—Prednisone—psoriasis	7.1e-05	0.00056	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Triamcinolone—psoriasis	7.1e-05	0.000559	CcSEcCtD
Cyclobenzaprine—Anxiety—Prednisone—psoriasis	7.08e-05	0.000558	CcSEcCtD
Cyclobenzaprine—Alopecia—Methotrexate—psoriasis	7.08e-05	0.000558	CcSEcCtD
Cyclobenzaprine—Insomnia—Dexamethasone—psoriasis	7.07e-05	0.000557	CcSEcCtD
Cyclobenzaprine—Insomnia—Betamethasone—psoriasis	7.07e-05	0.000557	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Cyclosporine—psoriasis	7.05e-05	0.000555	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Dexamethasone—psoriasis	7.02e-05	0.000553	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Betamethasone—psoriasis	7.02e-05	0.000553	CcSEcCtD
Cyclobenzaprine—Discomfort—Prednisone—psoriasis	7.02e-05	0.000553	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Prednisolone—psoriasis	6.9e-05	0.000544	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Betamethasone—psoriasis	6.88e-05	0.000542	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Dexamethasone—psoriasis	6.88e-05	0.000542	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Mycophenolate mofetil—psoriasis	6.87e-05	0.000542	CcSEcCtD
Cyclobenzaprine—Urticaria—Triamcinolone—psoriasis	6.85e-05	0.000539	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Methotrexate—psoriasis	6.83e-05	0.000538	CcSEcCtD
Cyclobenzaprine—Dizziness—Cyclosporine—psoriasis	6.81e-05	0.000537	CcSEcCtD
Cyclobenzaprine—Oedema—Prednisone—psoriasis	6.81e-05	0.000536	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Prednisone—psoriasis	6.81e-05	0.000536	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Dexamethasone—psoriasis	6.8e-05	0.000536	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Betamethasone—psoriasis	6.8e-05	0.000536	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Hydrocortisone—psoriasis	6.74e-05	0.000531	CcSEcCtD
Cyclobenzaprine—Fatigue—Dexamethasone—psoriasis	6.74e-05	0.000531	CcSEcCtD
Cyclobenzaprine—Fatigue—Betamethasone—psoriasis	6.74e-05	0.000531	CcSEcCtD
Cyclobenzaprine—Shock—Prednisone—psoriasis	6.7e-05	0.000528	CcSEcCtD
Cyclobenzaprine—Tachycardia—Prednisone—psoriasis	6.65e-05	0.000524	CcSEcCtD
Cyclobenzaprine—Dizziness—Mycophenolate mofetil—psoriasis	6.64e-05	0.000523	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Prednisone—psoriasis	6.58e-05	0.000519	CcSEcCtD
Cyclobenzaprine—Vision blurred—Methotrexate—psoriasis	6.57e-05	0.000518	CcSEcCtD
Cyclobenzaprine—Asthenia—Hydrocortisone—psoriasis	6.57e-05	0.000517	CcSEcCtD
Cyclobenzaprine—Vomiting—Cyclosporine—psoriasis	6.55e-05	0.000516	CcSEcCtD
Cyclobenzaprine—Rash—Cyclosporine—psoriasis	6.49e-05	0.000512	CcSEcCtD
Cyclobenzaprine—Anorexia—Prednisone—psoriasis	6.49e-05	0.000511	CcSEcCtD
Cyclobenzaprine—Dermatitis—Cyclosporine—psoriasis	6.49e-05	0.000511	CcSEcCtD
Cyclobenzaprine—Pruritus—Hydrocortisone—psoriasis	6.47e-05	0.00051	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Methotrexate—psoriasis	6.47e-05	0.00051	CcSEcCtD
Cyclobenzaprine—Headache—Cyclosporine—psoriasis	6.45e-05	0.000508	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Dexamethasone—psoriasis	6.44e-05	0.000508	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Betamethasone—psoriasis	6.44e-05	0.000508	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Dexamethasone—psoriasis	6.39e-05	0.000504	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Betamethasone—psoriasis	6.39e-05	0.000504	CcSEcCtD
Cyclobenzaprine—Vomiting—Mycophenolate mofetil—psoriasis	6.39e-05	0.000503	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Triamcinolone—psoriasis	6.35e-05	0.0005	CcSEcCtD
Cyclobenzaprine—Rash—Mycophenolate mofetil—psoriasis	6.33e-05	0.000499	CcSEcCtD
Cyclobenzaprine—Dermatitis—Mycophenolate mofetil—psoriasis	6.33e-05	0.000499	CcSEcCtD
Cyclobenzaprine—Headache—Mycophenolate mofetil—psoriasis	6.29e-05	0.000496	CcSEcCtD
Cyclobenzaprine—Malaise—Methotrexate—psoriasis	6.29e-05	0.000495	CcSEcCtD
Cyclobenzaprine—Vertigo—Methotrexate—psoriasis	6.26e-05	0.000494	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Hydrocortisone—psoriasis	6.26e-05	0.000493	CcSEcCtD
Cyclobenzaprine—Leukopenia—Methotrexate—psoriasis	6.24e-05	0.000492	CcSEcCtD
Cyclobenzaprine—Urticaria—Dexamethasone—psoriasis	6.21e-05	0.000489	CcSEcCtD
Cyclobenzaprine—Urticaria—Betamethasone—psoriasis	6.21e-05	0.000489	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Prednisone—psoriasis	6.2e-05	0.000489	CcSEcCtD
Cyclobenzaprine—Dizziness—Prednisolone—psoriasis	6.2e-05	0.000488	CcSEcCtD
Cyclobenzaprine—Asthenia—Triamcinolone—psoriasis	6.18e-05	0.000487	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Betamethasone—psoriasis	6.18e-05	0.000487	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Dexamethasone—psoriasis	6.18e-05	0.000487	CcSEcCtD
Cyclobenzaprine—Insomnia—Prednisone—psoriasis	6.16e-05	0.000485	CcSEcCtD
Cyclobenzaprine—Nausea—Cyclosporine—psoriasis	6.12e-05	0.000482	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Prednisone—psoriasis	6.11e-05	0.000482	CcSEcCtD
Cyclobenzaprine—Pruritus—Triamcinolone—psoriasis	6.1e-05	0.00048	CcSEcCtD
Cyclobenzaprine—Dizziness—Hydrocortisone—psoriasis	6.05e-05	0.000477	CcSEcCtD
Cyclobenzaprine—Convulsion—Methotrexate—psoriasis	6.04e-05	0.000476	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Prednisone—psoriasis	5.99e-05	0.000472	CcSEcCtD
Cyclobenzaprine—Nausea—Mycophenolate mofetil—psoriasis	5.97e-05	0.00047	CcSEcCtD
Cyclobenzaprine—Chest pain—Methotrexate—psoriasis	5.94e-05	0.000468	CcSEcCtD
Cyclobenzaprine—Myalgia—Methotrexate—psoriasis	5.94e-05	0.000468	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Prednisone—psoriasis	5.92e-05	0.000466	CcSEcCtD
Cyclobenzaprine—Rash—Prednisolone—psoriasis	5.91e-05	0.000466	CcSEcCtD
Cyclobenzaprine—Dermatitis—Prednisolone—psoriasis	5.9e-05	0.000465	CcSEcCtD
Cyclobenzaprine—Fatigue—Prednisone—psoriasis	5.87e-05	0.000463	CcSEcCtD
Cyclobenzaprine—Headache—Prednisolone—psoriasis	5.87e-05	0.000463	CcSEcCtD
Cyclobenzaprine—Discomfort—Methotrexate—psoriasis	5.86e-05	0.000462	CcSEcCtD
Cyclobenzaprine—Constipation—Prednisone—psoriasis	5.82e-05	0.000459	CcSEcCtD
Cyclobenzaprine—Vomiting—Hydrocortisone—psoriasis	5.82e-05	0.000458	CcSEcCtD
Cyclobenzaprine—Rash—Hydrocortisone—psoriasis	5.77e-05	0.000455	CcSEcCtD
Cyclobenzaprine—Dermatitis—Hydrocortisone—psoriasis	5.76e-05	0.000454	CcSEcCtD
Cyclobenzaprine—Confusional state—Methotrexate—psoriasis	5.74e-05	0.000452	CcSEcCtD
Cyclobenzaprine—Headache—Hydrocortisone—psoriasis	5.73e-05	0.000452	CcSEcCtD
Cyclobenzaprine—Dizziness—Triamcinolone—psoriasis	5.7e-05	0.000449	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Methotrexate—psoriasis	5.69e-05	0.000448	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Prednisone—psoriasis	5.61e-05	0.000442	CcSEcCtD
Cyclobenzaprine—Asthenia—Dexamethasone—psoriasis	5.61e-05	0.000442	CcSEcCtD
Cyclobenzaprine—Asthenia—Betamethasone—psoriasis	5.61e-05	0.000442	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Methotrexate—psoriasis	5.57e-05	0.000439	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Prednisone—psoriasis	5.57e-05	0.000439	CcSEcCtD
Cyclobenzaprine—Nausea—Prednisolone—psoriasis	5.57e-05	0.000439	CcSEcCtD
Cyclobenzaprine—Pruritus—Betamethasone—psoriasis	5.53e-05	0.000436	CcSEcCtD
Cyclobenzaprine—Pruritus—Dexamethasone—psoriasis	5.53e-05	0.000436	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Methotrexate—psoriasis	5.5e-05	0.000433	CcSEcCtD
Cyclobenzaprine—Vomiting—Triamcinolone—psoriasis	5.48e-05	0.000432	CcSEcCtD
Cyclobenzaprine—Nausea—Hydrocortisone—psoriasis	5.44e-05	0.000428	CcSEcCtD
Cyclobenzaprine—Rash—Triamcinolone—psoriasis	5.43e-05	0.000428	CcSEcCtD
Cyclobenzaprine—Dermatitis—Triamcinolone—psoriasis	5.43e-05	0.000428	CcSEcCtD
Cyclobenzaprine—Anorexia—Methotrexate—psoriasis	5.42e-05	0.000427	CcSEcCtD
Cyclobenzaprine—Urticaria—Prednisone—psoriasis	5.41e-05	0.000426	CcSEcCtD
Cyclobenzaprine—Headache—Triamcinolone—psoriasis	5.4e-05	0.000425	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Prednisone—psoriasis	5.38e-05	0.000424	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Betamethasone—psoriasis	5.35e-05	0.000422	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Dexamethasone—psoriasis	5.35e-05	0.000422	CcSEcCtD
Cyclobenzaprine—Hypotension—Methotrexate—psoriasis	5.32e-05	0.000419	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Methotrexate—psoriasis	5.18e-05	0.000408	CcSEcCtD
Cyclobenzaprine—Dizziness—Betamethasone—psoriasis	5.17e-05	0.000407	CcSEcCtD
Cyclobenzaprine—Dizziness—Dexamethasone—psoriasis	5.17e-05	0.000407	CcSEcCtD
Cyclobenzaprine—Insomnia—Methotrexate—psoriasis	5.15e-05	0.000406	CcSEcCtD
Cyclobenzaprine—Nausea—Triamcinolone—psoriasis	5.12e-05	0.000403	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Methotrexate—psoriasis	5.11e-05	0.000403	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Methotrexate—psoriasis	5.07e-05	0.0004	CcSEcCtD
Cyclobenzaprine—Somnolence—Methotrexate—psoriasis	5.06e-05	0.000399	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Prednisone—psoriasis	5.02e-05	0.000395	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Methotrexate—psoriasis	5.01e-05	0.000395	CcSEcCtD
Cyclobenzaprine—Vomiting—Dexamethasone—psoriasis	4.97e-05	0.000392	CcSEcCtD
Cyclobenzaprine—Vomiting—Betamethasone—psoriasis	4.97e-05	0.000392	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Methotrexate—psoriasis	4.95e-05	0.00039	CcSEcCtD
Cyclobenzaprine—Rash—Dexamethasone—psoriasis	4.93e-05	0.000388	CcSEcCtD
Cyclobenzaprine—Rash—Betamethasone—psoriasis	4.93e-05	0.000388	CcSEcCtD
Cyclobenzaprine—Dermatitis—Dexamethasone—psoriasis	4.93e-05	0.000388	CcSEcCtD
Cyclobenzaprine—Dermatitis—Betamethasone—psoriasis	4.93e-05	0.000388	CcSEcCtD
Cyclobenzaprine—Fatigue—Methotrexate—psoriasis	4.91e-05	0.000387	CcSEcCtD
Cyclobenzaprine—Headache—Betamethasone—psoriasis	4.9e-05	0.000386	CcSEcCtD
Cyclobenzaprine—Headache—Dexamethasone—psoriasis	4.9e-05	0.000386	CcSEcCtD
Cyclobenzaprine—Asthenia—Prednisone—psoriasis	4.89e-05	0.000385	CcSEcCtD
Cyclobenzaprine—Pruritus—Prednisone—psoriasis	4.82e-05	0.00038	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Methotrexate—psoriasis	4.69e-05	0.000369	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Prednisone—psoriasis	4.66e-05	0.000367	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Methotrexate—psoriasis	4.65e-05	0.000367	CcSEcCtD
Cyclobenzaprine—Nausea—Dexamethasone—psoriasis	4.64e-05	0.000366	CcSEcCtD
Cyclobenzaprine—Nausea—Betamethasone—psoriasis	4.64e-05	0.000366	CcSEcCtD
Cyclobenzaprine—Urticaria—Methotrexate—psoriasis	4.52e-05	0.000356	CcSEcCtD
Cyclobenzaprine—Dizziness—Prednisone—psoriasis	4.5e-05	0.000355	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Methotrexate—psoriasis	4.5e-05	0.000354	CcSEcCtD
Cyclobenzaprine—Vomiting—Prednisone—psoriasis	4.33e-05	0.000341	CcSEcCtD
Cyclobenzaprine—Rash—Prednisone—psoriasis	4.29e-05	0.000338	CcSEcCtD
Cyclobenzaprine—Dermatitis—Prednisone—psoriasis	4.29e-05	0.000338	CcSEcCtD
Cyclobenzaprine—Headache—Prednisone—psoriasis	4.27e-05	0.000336	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Methotrexate—psoriasis	4.19e-05	0.00033	CcSEcCtD
Cyclobenzaprine—Asthenia—Methotrexate—psoriasis	4.08e-05	0.000322	CcSEcCtD
Cyclobenzaprine—Nausea—Prednisone—psoriasis	4.04e-05	0.000319	CcSEcCtD
Cyclobenzaprine—Pruritus—Methotrexate—psoriasis	4.03e-05	0.000317	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Methotrexate—psoriasis	3.89e-05	0.000307	CcSEcCtD
Cyclobenzaprine—Dizziness—Methotrexate—psoriasis	3.76e-05	0.000296	CcSEcCtD
Cyclobenzaprine—Vomiting—Methotrexate—psoriasis	3.62e-05	0.000285	CcSEcCtD
Cyclobenzaprine—Rash—Methotrexate—psoriasis	3.59e-05	0.000283	CcSEcCtD
Cyclobenzaprine—Dermatitis—Methotrexate—psoriasis	3.58e-05	0.000282	CcSEcCtD
Cyclobenzaprine—Headache—Methotrexate—psoriasis	3.56e-05	0.000281	CcSEcCtD
Cyclobenzaprine—Nausea—Methotrexate—psoriasis	3.38e-05	0.000266	CcSEcCtD
